SCHEMBL23487553

SCHEMBL23487553

C#Cc1cc(-c2ccccc2-c2cccnc2)cc(-c2ccccc2-c2cccnc2)c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP11B1 P15538 4/20 0.46
CYP2A6 P11509 4/20 0.45
ALDH1A1 P00352 3/20 0.45
CYP1A2 P05177 2/20 0.45
CYP3A4 P08684 2/20 0.45
PTGS2 P35354 1/20 0.45
CYP11B2 P19099 4/20 0.41
CYP19A1 P11511 2/20 0.41
CYP17A1 P05093 1/20 0.41
MAPT P10636 2/20 0.41
POLB P06746 1/20 0.41
TSHR P16473 1/20 0.41
NPC1 O15118 1/20 0.41
RAB9A P51151 1/20 0.41
KCNA5 P22460 1/20 0.41
KDM4E B2RXH2 2/20 0.40
GLA P06280 1/20 0.40
GAA P10253 1/20 0.40
CYP2E1 P05181 1/20 0.40
CYP2D6 P10635 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29543420 0.86 CYP2A6 (0.61) CYP11B1CYP2A6ALDH1A1CYP1A2CYP3A4
SCHEMBL472043 0.86 CYP2A6 (0.61) CYP11B1CYP2A6ALDH1A1CYP1A2CYP3A4
SCHEMBL472037 0.84 CYP2A6 (0.58) CYP11B1CYP2A6ALDH1A1CYP1A2CYP3A4
SCHEMBL12819222 0.80 CYP2A6 (0.65) CYP11B1CYP2A6ALDH1A1CYP1A2CYP3A4
SCHEMBL30025900 0.80 CYP2A6 (0.65) CYP11B1CYP2A6ALDH1A1CYP1A2CYP3A4
SCHEMBL30026143 0.80 CYP2A6 (0.70) CYP11B1CYP2A6ALDH1A1CYP1A2CYP3A4
SCHEMBL20541087 0.80 CYP2A6 (0.70) CYP11B1CYP2A6ALDH1A1CYP1A2CYP3A4
SCHEMBL21110859 0.78 CYP2A6 (0.67) CYP11B1CYP2A6ALDH1A1CYP1A2CYP3A4
SCHEMBL12853987 0.78 CYP2A6 (0.67) CYP11B1CYP2A6ALDH1A1CYP1A2CYP3A4
SCHEMBL23487550 0.78 CYP2A6 (0.41) CYP11B1CYP2A6CYP3A4PTGS2CYP11B2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230056324-A1 METAL COMPLEXES MERCK PATENT GMBH (DE) 2023-02-23 US disclosed
WO-2021110720-A1 METAL COMPLEXES MERCK PATENT GMBH (DE) 2021-06-10 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230056324-A1 METAL COMPLEXES MCU, IMMT, SOD1 CYP11B1 1353/4885CYP2A6 4118/4885ALDH1A1 1713/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.